Pharmaceutical benefit scheme and cost containment in Taiwan's National Health Insurance

Journal of Pharmaceutical Finance, Economics and Policy

Volumn 12, Issue 2, 2003, Pages 133-149

  Huang, Weng Foung ^a   Chiang, Hung Chi ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Bureau of National Health Insurance Taiwan   (Taiwan)

Author keywords

Cost containment; National health insurance; Pharmacy benefits scheme; Taiwan

Indexed keywords

COST CONTROL; DRUG COST; HEALTH CARE POLICY; NATIONAL HEALTH INSURANCE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; TAIWAN;

EID: 4644281626     PISSN: 15385698     EISSN: None     Source Type: Journal    
DOI: 10.1300/J371v12n02_03     Document Type: Review

References (21)

1. EIU Healthcare Asia, The Economist Intelligence Unit. 1998 1st quarter.
2. National Health Insurance Profile. Taiwan: Bureau of National Health Insurance, 2000.
3. Chiang TL. Taiwan's 1995 health care reform. Health Policy. 1997;39(3):225-39.
4. National Health Insurance Profile. Taiwan: Bureau of National Health Insurance, 1997.
5. ROC 1999 Health Statistics and Trends. Taiwan: Department of Health, 1999.
6. Morlock L et al. National Health Insurance in Taiwan: Analysis of initial effect from an international perspective. Department of Health Policy and Management, School of Hygiene and Public Health, The Johns Hopkins University, 1997. Unpublished. A contract project by DOH, Taiwan, ROC (DOH-85-HI-009), 1996.
7. Chang HJ. National Health Insurance drug reimbursement policy: The way of the future? (Part I-Diagnosis). Bureau of National Health Insurance Home Page. URL: http://www.nhi.gov.tw. Accessed 2001 Oct.
8. Cheng SH, Chiang TL. The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA. 1997;278(2):89-93.
9. National Health Insurance: Moving from social solidarity to user fees. Taiwan Labor Front Home Page. URL: http://labor.ngo.org.tw Accessed 2001 Oct 17.
10. Stop the new co-payment regulation for pharmaceutical benefits in the National Health Insurance program. Taipei Association for the Promotion of Women's Rights Home Page. URL: http://newcongress.yam.org.tw/women. Accessed 2000 Oct 5.
11. Health Statistics. Taiwan: Department of Health, 1990-2000.
12. Chou LF. An economic model on the cost sharing of prescriptions drugs in the National Health Insurance. The National Chengchi University Press; 2000 May 11.
13. Shin BL et al. Evaluation of the new co-payment regulation for pharmaceutical benefits in Taiwan's National Health Insurance program. Contract research report funded by Research, Development and Evaluation Commission, Executive Yuan. Taiwan, ROC: 2000.
14. Press Release. Bureau of National Health Insurance. 2000 Oct 22.
15. Tackling pharmaceutical Black Hole-Fair Trade Act moves in. Ming-Shen Daily News, 2000 Oct 23.
16. NHI Guidelines for Pharmaceutical Price Adjustment. Taiwan: Bureau of National Health Insurance, 1999 Jul 19.
17. Department of Medical Affairs official announcement no. 30003876. Taiwan: Bureau of National Health Insurance.
18. Chen GT, Hsieh HI, Lin MS et al. The verification of prices of new drugs by the Bureau of National Health Insurance. Chin J Fam Med. 1998;8:210-8.
19. Huang WF, Lo KL, Chen LW. Comparison of Taiwan's NHI drug price and international drug price. Chin J Public Health. 1998;17(3):265-72.
20. Huang WF. Effect of including nonprescribed medicines in NHI's Pharmaceutical Benefit Scheme. Hospital (ROC). 1995;28(3):7-12.
21. Giuliani G, Selke G, Garattini L. The German experience in reference pricing. Health Policy. 1998;44:73-85.